Diagnosis, Diagnostic Test Accuracy (DTA) and Prognostic Reviews
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
Intervention Reviews
- Prevention of venous thromboembolism (VTE) in specific surgical/invasive procedure patients
- Prevention of VTE in acutely medically ill/high risk patients
- Prevention of VTE in other patient groups
- Prevention of post thrombotic syndrome (PTS)
- Treatment of VTE
- Treatment of DVT
- Treatment of PE
- Treatment of PTS
- Other

Diagnosis, Diagnostic Test Accuracy (DTA) and Prognosis reviews

Deep Vein Thrombosis (DVT)

Clinical decision rules for the diagnosis of deep vein thrombosis (title)

D-dimer tests for the diagnosis of deep venous thrombosis in symptomatic hospital outpatients with a clinical prediction rule (protocol)

Diagnostic tests for pregnancy-related deep vein thrombosis (protocol)

Duplex ultrasound for the diagnosis of symptomatic deep vein thrombosis in the lower limb (protocol)

Ultrasonography for clinically suspected upper extremity deep vein thrombosis (protocol)

Pulmonary Embolism (PE)

D-dimer test for excluding the diagnosis of pulmonary embolism

Imaging for the exclusion of pulmonary embolism in pregnancy

Sex as a prognostic factor in patients with symptomatic acute pulmonary embolism (protocol)

Intervention reviews

Prevention of venous thromboembolism (VTE) in specific surgical/invasive procedure patient groups

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair

Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty

Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement

Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization 

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair (protocol)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement

Heparin dose for thrombosis prophylaxis during peripheral vascular angioplasty (protocol)

Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures

Interventions for the primary prevention of venous thromboembolism for hip fracture surgery (protocol)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Low molecular weight heparin for prevention of microvascular occlusion in digital replantation

Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol)

Pharmacological interventions for preventing venous thromboembolism in patients undergoing bariatric surgery

Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery

Primary prophylaxis for venous thromboembolism in patients undergoing implantation of pacemakers or cardioverter-defibrillators (title)

Primary prophylaxis for venous thromboembolism in patients undergoing major amputation of the lower extremity

Prevention of VTE in acutely medically ill/high risk patient groups

Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)

Novel oral anticoagulants for prevention of venous thromboembolism in acutely ill medical patients (title)

Standard versus extended duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients (protocol)

Prevention of VTE in other patient groups

Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid Syndrome (protocol)

Antiplatelet and anticoagulant agents for primary prevention of thrombosis in patients with antiphospholipid antibodies

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism

Compression stockings for preventing deep vein thrombosis in airline passengers

Graduated compression stockings for prevention of deep vein thrombosis

Heparin-bonded catheters for prolonging the patency of central venous catheters in children

Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults

Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children

Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis

Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization

Neuromuscular electrical stimulation for the prevention of venous thromboembolism

Pentasaccharides for the prevention of venous thromboembolism

Prevention of recurrent venous thromboembolism: an overview of Cochrane reviews (title)

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Prophylactic anticoagulants for non-hospitalised people with COVID-19 (protocol)

Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism

Statins for the prevention of primary venous thromboembolism (protocol)

Statins for primary prevention of venous thromboembolism

Vena caval filters for the prevention of pulmonary embolism

Vena caval filters for the prevention of pulmonary embolism in people at high risk of, or with established venous thromboembolism (protocol)

Prevention of Post Thrombotic Syndrome (PTS)

Compression therapy for prevention of post-thrombotic syndrome

Rutosides for prevention of post thrombotic syndrome

Treatment of VTE

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism 

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism

Treatment for superficial thrombophlebitis of the leg

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

Warfarin initiation nomograms for venous thromboembolism

Treatment of DVT

Angioplasty for deep venous thrombosis (protocol)

Antiplatelet agents for the treatment of deep venous thrombosis

Home versus in-patient treatment for deep vein thrombosis

Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis

Pentasaccharides for the treatment of deep vein thrombosis

Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis

Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb

Thrombolysis for acute upper extremity deep vein thrombosis

Treatment of distal deep vein thrombosis

Treatment of PE

Anticoagulant treatment for subsegmental pulmonary embolism

Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism

Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism

Outpatient versus inpatient treatment for acute pulmonary embolism 

Thrombolytic therapy for pulmonary embolism

Treatment of PTS

Compression therapy for treating post-thrombotic syndrome

Rutosides for treatment of post-thrombotic syndrome

Other

Effect of testing for cancer on cancer‐ and VTE‐related mortality and morbidity in patients with unprovoked VTE

Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism

Thrombophilia testing for prevention of recurrent venous thromboembolism (stable)

Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients